Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Chimeric Therapeutics Ltd. has announced the cessation of 5,816,912 securities due to the lapse of conditional rights. The conditions for these securities were not met, leading to their expiration on December 20, 2024. This development might influence investor perspectives on the company’s stock performance.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.